본문 바로가기
KERD
논문KCI 등재

六君子湯이 Glutamate에 의한 C6 신경교세포의 Apoptosis에 미치는 영향

Effect of Yukgunja-tang on Glutamate-induced Apoptosis in C6 Glial Cells

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류한의학

초록

Objective : The water extract of Yukgunja-tang(YGJT) has been traditionally used in treatment of qi deficiency and phlegm in Oriental medicine. However, little is known about the mechanism by which YGJT protects neuronal cells from injury damages. Therefore, this study was designed to evaluate the protective effects of YGJT on C6 glial cells by glutamate-induced cell death. Methods : The present study describes glutamate, which is known as an excitatory neurotransmitter, related with oxidative damages, and YGJT, which shows protective effects against glutamate-induced C6 glial cell death. One of the main mediators of glutamate-induced cytotoxicity was known on the generation of reactive oxygen species(ROS) via activation of NADPH oxidase (NOX). The protective effects of antioxidant(NAC) and NOX inhibitor(apocynin) on the glutamate-induced C6 glial cells were determined by a MTT reduction assay. Result : YGJT inhibited glutamate-induced ROS generation via inhibition of NOX expression on glutamate-stimulated C6 glial cells. Furthermore, YGJT attenuated glutamate-induced caspase activation. These results suggest that YGJT could be a new potential candidate against glutamate-induced oxidative stress and cell death. Conclusion : These findings indicate that in C6 glial cells, ROS plays an important role of glutamate-induced cell death and that YGJT may prevent cell death from glutamate-induced cell death by inhibiting the ROS generation.

Abstract

Objective : The water extract of Yukgunja-tang(YGJT) has been traditionally used in treatment of qi deficiency and phlegm in Oriental medicine. However, little is known about the mechanism by which YGJT protects neuronal cells from injury damages. Therefore, this study was designed to evaluate the protective effects of YGJT on C6 glial cells by glutamate-induced cell death. Methods : The present study describes glutamate, which is known as an excitatory neurotransmitter, related with oxidative damages, and YGJT, which shows protective effects against glutamate-induced C6 glial cell death. One of the main mediators of glutamate-induced cytotoxicity was known on the generation of reactive oxygen species(ROS) via activation of NADPH oxidase (NOX). The protective effects of antioxidant(NAC) and NOX inhibitor(apocynin) on the glutamate-induced C6 glial cells were determined by a MTT reduction assay. Result : YGJT inhibited glutamate-induced ROS generation via inhibition of NOX expression on glutamate-stimulated C6 glial cells. Furthermore, YGJT attenuated glutamate-induced caspase activation. These results suggest that YGJT could be a new potential candidate against glutamate-induced oxidative stress and cell death. Conclusion : These findings indicate that in C6 glial cells, ROS plays an important role of glutamate-induced cell death and that YGJT may prevent cell death from glutamate-induced cell death by inhibiting the ROS generation.

참고문헌 (55)

  1. Lebouvier T, "The second brain and Parkinson's disease", Eur J Neurosci., 30(5), pp.735~741 (2009)
  2. Chitnis S, "Rivastigmine in Parkinson's disease dementia", Expert Opin Drug Metab Toxicol, 5(8), pp.941~955 (2009)
  3. Cunningham LM, "A review of assistive technologies for people with Parkinson's disease", Technol Health Care., 17(3), pp.269~279 (2009)
  4. Białecka M, "Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson's disease", Neurol Neurochir Pol, 43(3), pp.272~285 (2009)
  5. Robottom BJ, "Dementia in Parkinson's disease", Int Rev Neurobiol, 84, pp.229~244 (2009)
  6. Ghibom Bhak, "Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation", BMB reports, 42(9), pp.541~551 (2009), 한국생화학분자생물학회
  7. Kannan P, "Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications", Clin Pharmacol Ther, 86(4), pp.368~377 (2009)
  8. Kovari E, "Neuropathology of Lewy body disorders", Brain Res Bull, 80(4), pp.203~210 (2009)
  9. Chen JQ, "Regulation of mitochondrial respiratory chain biogenesis by estrogens", estrogen receptors and physiological, pathological and pharmacological implications, 2009, pp.1793(10), 1540~1570
  10. Deslandes A, "Exercise and mental health: many reasons to move", Neuropsychobiology, 59(4), pp.191~198 (2009)
  11. Modi G, "Nanotechnological applications for the treatment of neurodegenerative disorders", Prog Neurobiol., 88(4), pp.272~285 (2009)
  12. Zuccato C, "Brain-derived neurotrophic factor in neurodegenerative diseases", Nat Rev Neurol, 5(6), pp.311~322 (2009)
  13. Uversky VN, "Intrinsic disorder in proteins associated with neurodegenerative diseases", Front Biosci., 14, pp.5188~5238 (2009)
  14. 大韓神經外科學會, "神經外科學", pp.276~278 (1997), 中央文化社
  15. Peter L, "Ischemic Cell Death in Brain Neurons", Physiol. Review., 70, pp.1499~ (1997)
  16. Hisano K, "Protective effects of the free radical scavenger edaravone against glutamate neurotoxicity in nearly pure neuronal culture", J Anesth, 23(3), pp.363~369 (2009)
  17. Kaur C, "Hypoxia-ischemia and retinal ganglion cell damage", Clin Ophthalmol, 2(4), pp.879~889 (2008)
  18. Jantas D, "Effects of TRH and its analogues on primary cortical neuronal cell damage induced by various excitotoxic, necrotic and apoptotic agents", Neuropeptides, 43(5), pp.371~385 (2009)
  19. Bei W, "Neuroprotective effects of a standardized flavonoid extract from Diospyros kaki leaves", J Ethnopharmacol, 126(1), pp.134~142 (2009)
  20. Liu L, "Tissue kallikrein alleviates glutamate-induced neurotoxicity by activating ERK1", J Neurosci Res., 87(16), pp.3576~3590 (2009)
  21. Saha RN, "TNF-alpha preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein", J Immunol, 183(3), pp.2068~2078 (2009)
  22. Zhu X, "PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium", Toxicol Appl Pharmacol, 240(2), pp.286~291 (2009)
  23. 虞摶, "醫學正傳", pp.133~ (1981), 人民衛生出版社
  24. 徐春甫, "古今醫統秘方", pp.1999~ (1982), 金剛出版社
  25. 李梴, "醫學入門", pp.417~ (1982), 大星文化社
  26. 朱震亨, "丹溪心法", pp.194~ (1982), 大星文化社
  27. 汪昻, "편집의방집해", pp.26~ (2004), 도서출판반룡
  28. 龔廷賢, "萬病回春", pp.150~ (1972), 杏林書院
  29. 이승재, "四君子湯, 二陳湯 및 六君子湯이 高脂血症에 미치는 影響", 대한한방내과학회지, 15(1), pp.45~59 (1994)
  30. 정현우, "四君子湯, 二陳湯, 六君子湯이 腦血流力學 변동에 미치는 실험적 연구", 동의생리병리학회지, 18(1), pp.75~83 (2004), 대한동의병리학회
  31. 이석진, "六君子湯과 竹瀝 혼합물이 국소 뇌혈류량 및 평균혈압에 미치는 효과", 동의생리병리학회지, 21(1), pp.54~61 (2007), 대한동의병리학회
  32. 辛民敎, "新增方藥合編", pp.160~ (2003), 永林社
  33. 윤미영, "석곡MeOH 추출물이 H2O2에의한신경세포 보호효과에 미치는 영향", Journal of the Korean Society for Applied Biological Chemistry, 50(1), pp.63~67 (2007), 한국응용생명화학회
  34. Sagara, Y, "Cellular mechanisms of resistance to chronic oxidative stress", Free Radic. Biol. Med., 24, pp.1375~1389 (1998)
  35. 이양숙, "구릿대 잎 추출물의 항산화 효과 및 생리활성", 한국식품저장유통학회지, 14(1), pp.78~86 (2007), 한국식품저장유통학회
  36. 김동조, "Paraquant 유도 산화적 스트레스에 대한 홍삼 사포닌의 항산화 효과", Journal of Ginseng Research, 28(1), pp.5~10 (2004), 인삼학회
  37. Ames, B. N, "Oxidants, antioxidants, and the degenerative diseases of aging", Proc. Natl. Acad. Sci. USA., 90, pp.7915~7922 (1993)
  38. Halliwell, B, "DNA damage by oxygen derived species", FEBS Lett, 281, pp.9~19 (1991)
  39. Vannucci RC, "Intervention for perinatal hypoxic-ischemic encephalopathy", Pediatrics, 100, pp.1004~1014 (1997)
  40. Taylor DL, "Oxidative metabolism, apoptosis and perinatal brain injury", Brain Pathol, 9, pp.93~117 (1999)
  41. Mishra OP, "Cellular mechanism of hypoxic injury in the developing brain", Brain Res. Bull., 48, pp.233~238 (1999)
  42. Olney JW, "Brain lesions, obesity and other disturbance in mice treated with monosodium glutamate", Science, 164, pp.719~721 (1969)
  43. Ford LM, "MK-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats", Arch. Neurol, 6, pp.1090~1096 (1989)
  44. Johnston MV, "Novel treatments after experimental brain injury", Semin. Neonatol, 5, pp.75~86 (2000)
  45. Monagham DT, "The excitatory amino acid receptors : their classes, pharmacology, and distinct properties in the function of the central nervous system", Ann. Rev. Pharmacol. Toxicol., 29, pp.365~402 (1989)
  46. Schoepfer R, "Molecular biology of glutamate receptors", Prog. Neurobiol, 42, pp.353~357 (1994)
  47. Graham SH, "Limiting ischemic injury by inhibition of exciting amino acid release", J. Cereb. Blood Flow. Metab, 13, pp.88~97 (1993)
  48. Nicoletti F, "The activation of inositol phospholipid metabolism as a single-transducing system for excitatory aminoacids in primary cultures of cerebral granular cells", J. Neurochem, 6, pp.1905~1911 (1986)
  49. Vexler ZS, "Molecular and biochemical mechanism of perinatal brain injury", Semin. Neonatol, 6, pp.99~108 (2001)
  50. 許浚, "東醫寶鑑", pp.218~ (2005), 동의보감출판사
  51. 김중길, "한의 중풍변증 표준안-Ⅰ에 대한 보고", 동의생리병리학회지, 20(1), pp.229~234 (2006), 대한동의병리학회
  52. 강지선, "한국형 중풍변증표준안-Ⅱ의 변증별 사용 처방에 대한 연구", 동의생리병리학회지, 22(2), pp.469~480 (2008), 대한동의병리학회
  53. Li H, "D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells", Hypertension, 53(6), pp.1054~1061 (2009)
  54. Han W, "Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells", Hypertension, 51(2), pp.481~487 (2008)
  55. Xie XQ, "The effects of arginine and selective inducible nitric oxide synthase inhibitor on pathophysiology of sepsis in a CLP model", J Surg Res., 146(2), pp.298~303 (2008)

관련 논문AI추천

이 간행물의 다른 논문 (24건)